Serum Golgi protein 73 is a marker comparable to APRI for diagnosing significant fibrosis in children with liver disease

[1]  Q. Xie,et al.  Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[2]  Shuhong Liu,et al.  Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma , 2017, Oncotarget.

[3]  A. Feldstein,et al.  Similarities and differences between pediatric and adult nonalcoholic fatty liver disease. , 2016, Metabolism: clinical and experimental.

[4]  Wei Wu,et al.  Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis , 2015, Hepatitis monthly.

[5]  M. Marczyńska,et al.  Is liver biopsy still needed in children with chronic viral hepatitis? , 2015, World journal of gastroenterology.

[6]  T. Kisseleva,et al.  Reversibility of liver fibrosis. , 2015, Clinics and research in hepatology and gastroenterology.

[7]  P. Scheuer,et al.  Scheuer's Liver Biopsy Interpretation , 2015 .

[8]  Lifei Liu,et al.  Serum Golgi Protein 73 (GP73) is a Diagnostic and Prognostic Marker of Chronic HBV Liver Disease , 2015, Medicine.

[9]  P. Vajro,et al.  Liver biopsy in children: position paper of the ESPGHAN Hepatology Committee. , 2015, Journal of pediatric gastroenterology and nutrition.

[10]  P. Bedossa.  Reversibility of hepatitis B virus cirrhosis after therapy: who and why? , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[11]  Meijuan Wei,et al.  Serum Golgi protein 73 levels and liver pathological grading in cases of chronic hepatitis B , 2014, Molecular medicine reports.

[12]  Jing Zhang,et al.  GP73, a new marker for diagnosing HBV-ACLF in population with chronic HBV infections. , 2014, Diagnostic microbiology and infectious disease.

[13]  Haifeng Xu,et al.  Golgi protein 73, not Glypican‐3, may be a tumor marker complementary to α‐Fetoprotein for hepatocellular carcinoma diagnosis , 2014, Journal of gastroenterology and hepatology.

[14]  Y. Qiao,et al.  Serum GP73, a Marker for Evaluating Progression in Patients with Chronic HBV Infections , 2013, PloS one.

[15]  John F. Flaherty,et al.  Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study , 2013, The Lancet.

[16]  D. Mann,et al.  Clinical evidence for the regression of liver fibrosis. , 2012, Journal of hepatology.

[17]  Xin Yin,et al.  Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysis , 2012, BMC Cancer.

[18]  Yaping Tian,et al.  Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases , 2011, International journal of cancer.

[19]  Xinxin Lu,et al.  Golgi protein 73(GP73), a useful serum marker in liver diseases , 2011, Clinical chemistry and laboratory medicine.

[20]  A. Alisi,et al.  Liver fibrosis in paediatric liver diseases. , 2011, Best practice & research. Clinical gastroenterology.

[21]  S. Du,et al.  Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma , 2010, Gut.

[22]  F. Wrba,et al.  Hepatocyte GP73 expression in Wilson disease. , 2009, Journal of hepatology.

[23]  Mary Ann Comunale,et al.  GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. , 2005, Journal of hepatology.

[24]  B. Bacon,et al.  Disease- and Cell-Specific Expression of GP73 in Human Liver Disease , 2004, American Journal of Gastroenterology.

[25]  A. Maitra,et al.  GP73 and Liver Disease: A (Golgi) Complex Enigma , 2004, American Journal of Gastroenterology.

[26]  J. Kalbfleisch,et al.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.

[27]  G. Bulla,et al.  Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease , 2002, Hepatology.

[28]  W. Balistreri,et al.  Pediatric liver disease in the United States: Epidemiology and impact , 2002, Journal of Gastroenterology and Hepatology.

[29]  R. Kladney,et al.  GP73, a novel Golgi-localized protein upregulated by viral infection , 2000, Gene.

[30]  G. Biondi-Zoccai.  Diagnostic Meta-Analysis , 2018, Springer International Publishing.

[31]  MariaPokorska-Spiewak,et al.  Is liver biopsy still needed in children with chronic viral hepatitis , 2015 .

[32]  ScienceDirect,et al.  Clinics and research in hepatology and gastroenterology , 2011 .

[33]  P. Scheuer,et al.  Liver Biopsy Interpretation , 1973 .